Bcr-abl protein detection in peripheral blood mononuclear cells for follow-up of chronic myelogenous leukaemia patients

European Journal of Haematology

Volumn 62, Issue 3, 1999, Pages 149-154

  Schleuning, Michael ^a   Mittermuller J ^a,b   Kolb, H J ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Bcr abl; CML; Cytogenetics; p210; Western blot

Indexed keywords

BCR ABL PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; BONE MARROW CELL; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MONONUCLEAR CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032989038     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01737.x     Document Type: Article

References (26)

1. NOWELL PC, HUNGERFORD DA. A minute chromosome in human chronic granulocytic leukemia. Science 1960;132:1497-1499.
2. 1 chromosome positive acute lymphoblastic leukaemia. Br J Haematol 1987;67:319-324.
3. YOSHIDA A, KISHI S, KITA K, KAMADA N, NAKAMURA T, UEDA T. Molecular analysis of a case of Philadelphia chromosome-positive acute myeloid leukaemia. Anticancer Res 1997;17:625-628.
4. SHTIVELMAN E, GALE RP, DREAZON O, et al. BCR-ABL RNA in patients with chronic myelogenous leukemia. Blood 1987;69:971-973.
5. SHTIVELMAN E, LIFSHITZ B, GALE RP, ROE BA, CANAANI E. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 1986;47:277-284.
6. c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc Natl Acad Sci USA 1986;83:9768-9772.
7. CARPINO N, WISNIEWSKI D, STRIFE A, et al. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 1997;88:197-204.
8. HERMANS A, HEISTERKAMP N, VON LINDERN N, et al. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 1987;51:33-40.
9. LUGO TG, PENDERGAST A-M, MULLER AJ, WITTE ON. Tyrosine kinase activity and transformation potency of BCR-ABL oncogene products. Science 1990;247:1079-1082.
10. CHAN LC, KARHI KK, RAYTER SI, et al. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukemia. Nature 1987;324:635-637.
11. LEE M-S, LEMAISTRE A, KANTARIJAN HM, et al. Detection of two alternative BCR-ABL mRNAs and minimal residual disease in Philadelphia chromosome-positive chronic myelogenous leukemia by polymerase chain reaction. Blood 1989;73:2165-2170.
12. SEONG D, GIRALT S, FISCHER H, et al. Usefulness of detection of minimal residual disease by "hypermetaphase" fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. Bone Marrow Transplant 1997;19:565-570.
13. GUO JQ, WANG JYJ, ARLINGHAUS RB. Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients. Cancer Res 1991;51:3048-3051.
14. GUO JQ, LIAN JY, XIAN YM, et al. BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy. Blood 1994;83:3629-3637.
15. LOZZIO CB, LOZZIO BB. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 1975;45:321-334.
16. COLLINS S, COLEMAN H, GALLAGHER RE. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 1977;270:347-349.
17. KOEFFLER HP, GOLDE DW. Acute myelogenous leukemia; a human cell line response to colony stimulating activity. Science 1987;200:1153-1154.
18. MAURER J, THIEL E. Rapid detection of chimeric bcr/abl mRNAs in acute lymphoblastic and chronic myeloid leukemia by the polymerase chain reaction. Blut 1990;61:350-353.
19. GUO JQ, LIAN J, GLASSMAN A, et al. Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients. Am J Clin Pathol 1996;106:442-448.
20. HAFERLACH T, WINKEMANN M, NICKNIG C, et al. Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques. Br J Haematol 1997;97:99-106.
21. BEDI A, ZEHNBAUER BA, COLLECTOR MI, et al. Bcr-abl gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood 1993;81:2898-2902.
22. KONOPKA JB, WATANABE SM, WITTE ON. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984;37:1035-1042.
23. SAGLIO G, PANE F, GOTTARDI E, et al. Consistent amounts of acute leukemia-associated p190 BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 1996;87:1075-1080.
24. BSEISO AW, KANTARJIAN HM, GUO JQ, et al. Analysis of the BCR-ABL protein in Philadelphia chromosome-positive adult acute lymphocytic leukemia. Leukemia 1997;11:1583-1587.
25. LIN F, VAN RHEE F, GOLDMAN JM, CROSS NCP. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 1996;87:4473-4478.
26. KANTARJIAN HM, SMITH TL, O'BRIAN S, BERAN M, PIERCE S, TALPAZ M. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-A therapy. Ann Intern Med 1995;122:254-261.